Your browser doesn't support javascript.
loading
Cost-effectiveness of Novel Treatment Sequences for Transplant-Ineligible Patients With Multiple Myeloma.
Blommestein, Hedwig M; Franken, Margreet G; van Beurden-Tan, Chrissy H Y; Blijlevens, Nicole M A; Huijgens, Peter C; Sonneveld, Pieter; Uyl-de Groot, Carin A; Zweegman, Sonja.
  • Blommestein HM; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.
  • Franken MG; Institute of Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.
  • van Beurden-Tan CHY; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
  • Blijlevens NMA; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Huijgens PC; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Sonneveld P; Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
  • Uyl-de Groot CA; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.
  • Zweegman S; Institute of Medical Technology Assessment, Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.
JAMA Netw Open ; 4(3): e213497, 2021 03 01.
Article en En | MEDLINE | ID: mdl-33779744
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Órganos / Años de Vida Ajustados por Calidad de Vida / Toma de Decisiones Clínicas / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Órganos / Años de Vida Ajustados por Calidad de Vida / Toma de Decisiones Clínicas / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article